Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Microbial pathogenesis in inflammatory bowel diseases
Studies examining fibroblast and endothelial cell systems show increased phosphorylation of focal adhesion kinase and paxillin, two proteins central to cytoskeletal organization and cell adhesion signaling
2022;37(18):e146
What I didn't obsess over Core Web Vitals at launch: Yes, performance matters
10.1136/bmj-2023-076410 91 YenF.-S.HouM.-C.Cheng-ChungW
US$ 22.95
US$ 23.49
US$ 28.11
US$ 22.62
US$ 23.47
US$ 28.36
US$ 23.42
